A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Epistemonikos ID: 2f56a27925e02eefab60b257c74beb079027ecde
First added on: Mar 27, 2025